MARKET

AGEN

AGEN

Agenus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.350
-0.090
-3.69%
Closed 16:56 03/27 EDT
OPEN
2.370
PREV CLOSE
2.440
HIGH
2.480
LOW
2.300
VOLUME
1.78M
TURNOVER
--
52 WEEK HIGH
4.570
52 WEEK LOW
1.820
MARKET CAP
379.74M
P/E (TTM)
-2.9324
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AGEN stock price target is 5.50 with a high estimate of 6.00 and a low estimate of 5.00.

EPS

AGEN News

More
  • Agenus (AGEN) Moves to Buy: Rationale Behind the Upgrade
  • Zacks · 5d ago
  • Top Pharma Stocks Under $5
  • MotleyFool.com · 5d ago
  • Edited Transcript of AGEN earnings conference call or presentation 12-Mar-20 12:30pm GMT
  • Thomson Reuters StreetEvents · 03/19 14:54
  • The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
  • Benzinga · 03/18 11:36

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About AGEN

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.
More

Webull offers kinds of Agenus Inc stock information, including NASDAQ:AGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGEN stock news, and many more online research tools to help you make informed decisions.